April 17, 2018 / 7:12 PM / 3 days ago

Canada says working with U.S. FDA to address EpiPen shortage

TORONTO, April 17 (Reuters) - Canada’s government health agency said on Tuesday it is working with the U.S. Food and Drug Administration to address a shortage of Mylan’s EpiPen allergy antidote that his hit several countries outside of the United States, where it is manufactured.

The efforts include “exploring access to international supply,” a Health Canada spokeswoman told Reuters in an emailed statement. (Reporting by Anna Mehler Paperny Editing by Tom Brown)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below